Invention Grant
- Patent Title: Injectable vaccines against multiple meningococcal serogroups
-
Application No.: US15962507Application Date: 2018-04-25
-
Publication No.: US10668142B2Publication Date: 2020-06-02
- Inventor: Paolo Costantino
- Applicant: GLAXOSMITHKLINE BIOLOGICALS, SA
- Applicant Address: BE Rixensart
- Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee Address: BE Rixensart
- Agent Lisa Matovcik
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@6588527c com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@195208
- Main IPC: A61K39/095
- IPC: A61K39/095 ; A61K9/00 ; C07K14/22 ; A61K39/08 ; A61K39/116 ; A61K39/05 ; A61K39/385 ; A61K39/00 ; A61K39/102 ; A61K39/09 ; A61K39/29 ; A61K39/02 ; A61K39/12
Abstract:
An injectable immunogenic composition comprising capsular saccharides from at least two of serogroups A, C, W135 and Y of Neisseria meningitidis, wherein said capsular saccharides are conjugated to carrier protein(s) and/or are oligosaccharides, and wherein (i) the composition comprises
Public/Granted literature
- US20180243395A1 INJECTABLE VACCINES AGAINST MULTIPLE MENINGOCOCCAL SEROGROUPS Public/Granted day:2018-08-30
Information query
